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1. Introduction 
Bacterial artificial chromosomes (BACs) constitute minimal components of various whole 
genome-sequencing projects, including our own. The recent innovation of efficient 
recombinogenic bacterial strains allows systematic BAC modifications (i.e. recombineering; 
Reviewed in Copeland et al., 2001), setting BACs as an ideal experimental basis for 
functional genomics with their broad coverage of transcriptional regulatory elements. For 
instance, in the field of neuroscience, the GENSAT project extensively modified mouse BAC 
clones, covering gene transcriptional units preferentially expressed in the nervous system, 
and generated hundreds of BAC transgenic (Tg) mouse lines from those modified BACs 
(Gong et al., 2003). These BAC-Tg lines successfully recapitulated complex gene expression 
profiles in the nervous system (Gong et al., 2003), providing a rigid analytical platform so as 
to be able to answer the fundamental question of how tens of millions of neurons and 
thousands of cell-types can become elaborate interconnected circuitries in the brain by using 
only twenty-thousand sets of gene transcriptional activities. 
Classic cadherins are adhesion molecules at the cell-cell adherence junction and the neuron-
neuron synapse peri-active zone (i.e. puncta adherentia) whose expression differentially 
delineates elaborated cytoarchitectures, such as layers and nuclei that constitute the basis for 
neural circuit formation in the vertebrate nervous system (Takeichi, 1995; Takeichi and Abe, 
2005). Classic cadherins have 20 subclass members encoded by different genes, with each 
subclass harbouring distinct cell adhesiveness (Takeichi, 1995). In the in vitro aggregation 
assay system, it has been demonstrated that dissociated cells expressing the same sets of the 
classic cadherin subclass at a same level tend to make aggregates depending upon the 
calcium ion (Nose et al., 1988; Steinberg et al., 1994). Noticeably, in the developing nervous 
system, each classic cadherin subclass shows unique expression patterns, and such 
expression profiles are dynamically regulated during morphogenetic processes (Gumbiner, 
2005; Redies, 2000). For instance, during chickens’ early neural development, prospective 
neural tissue begins to express N-cadherin and, at the interface between the N-cadherin 
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expressing cells and the surface ectodermal cells with E-cadherin expression, a Cadherin-6B 
positive, N-cadherin negative domain appears to segregate neural crest cells. Once they 
have emigrated from the neural plate/tube, neural crest cells finally begin to express 
Cadherin-7. This dynamical cadherin class switch is critical to the regulation of neurulation 
dynamics, since ectopically expressed N-cadherin perturbs the neural tube segregations 
from the ectoderm and/or the neural crest cell emigrations (Fujimori et al., 1990; Nakagawa 
& Takeichi, 1998). It is thus suggested that spatio-temporally regulated cadherin expression 
plays a pivotal role in animal morphogenetic processes. 
While the physiological significance of differential cadherin expression profiles and/or 
cadherin class switches in neural development has been implicated, their gene regulatory 
mechanisms are largely unknown, due to the huge size and complex organisation of cadherin 
gene structures. Understanding the regulatory mechanisms for classic cadherin expression is 
crucial from a clinical point of view, as many cancer cells lose precise expression profiles of 
cadherins, resulting in the hyper-growth of cells and/or cell metastasis (Takeichi, 1995). 
In our early studies, we have applied BAC-based technologies so as to screen gene regulatory 
patterns for a subclass of classic cadherins, cadherin-6 (Cdh6) whose gene structure is too large 
and complex for the identification of its promoter/enhancers by conventional methods. We 
succeeded in finding out that different genomic territories, located as far as 100-kbp upstream 
or downstream from the transcription start-site, is required for Cdh6 expression at the defined 
time and place (Inoue et al., 2008a; Inoue et al., 2008b). Here, we extend the enhancer screening 
and reveal that a 6-kbp sized 3 prime intergenic region is critical in order to yield Cdh6 
expression along the somatosensory barrel, a distinct cytoarchitecture of the mouse cerebral 
cortex, at around postnatal day 7 (P7). Additionally, by taking advantage of the Cdh6 
enhancer/promoter activity identified, we establish a BAC Tg mouse line in which 
somatosensory barrels are stably illuminated by exogenous green fluorescent protein (GFP) 
expression, allowing us to suggest the roles of the retinoic acid (RA) related signalling 
pathway during cortical barrel field development and/or patterning. These results clearly 
demonstrate the strictly divisible Cdh6 regulatory pattern along functional brain units, and the 
value of BAC-based experimental strategies in the field of developmental neuroscience. 
2. Protocols 
2.1 BAC modification via homologous recombination in bacterial cells 
The recombinogenic bacterial strain EL250 (Lee et al., 2001) was used in the present study. 
For the homologous recombination, ~1-kbp homology arms were amplified from the BAC 
clone of interest (=RP23-78N21 in this study) by means of a polymerase chain reaction 
(PCR), and were cloned into a conventional TA cloning vector (pGEM-T-Easy; Promega). 
For homologous recombination, beta-galactosidase (LacZ) and a growth-associated protein-
43 tagged enhanced green fluorescent protein (GAP43-EGFP) gene expression cassette were 
inserted into the BAC clone of interest; a LacZ/GAP-EGFP gene expression cassette and a 
gene cassette for clone selections (e.g. ampicillin resistant gene, kanamycin resistant gene, 
etc.) were cloned in between the homology arms and the fragment containing arms as well 
as reporter/selection gene cassettes which were purified by means of agarose gel 
electrophoresis after complete digestion with proper restriction enzymes. For homologous 
recombination mediated deletion of given territories from the BAC clone of interest, only the 
selection cassette was cloned in between the homology arms and the portion containing 
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arms, and the selection cassette was isolated as described above. The selection cassette was 
put in between two FRT sites for its eventual excision by the inducible Flpe gene (see below). 
The recombination system in EL250 cells (Lee et al., 2001) was activated via heat shock, and 
their electroporation-competency (EP) was conferred on ice so as to maintain the 
recombinogenic activity. Briefly, EL250 cells that harbour the BAC clone of interest were pre-
cultured in 50 ml of LB without antibiotic at 32˚C, until an optical density of 600 nm (OD600) 
was reached at 0.5. By adding 2.5 ml of the overnight saturated culture to 50 ml of LB, it 
normally took ~90 min to obtain 0.5 OD600 in the shaking culture at 32˚C. Then, 15 ml of the 
culture was heat-shocked at 42˚C for 15 min in a water bath with the shaker’s agitation, while 
another 15 ml was maintained in the shaking culture at 32˚C as the control. Both of the cultures 
were subsequently placed on ice for 15min, centrifuged, and quickly washed three times by 
ice-cold water in order to draw the electro-competency for the heat-shocked cells. A few 
hundred nano-grams of the resultant purified fragment was then electroporated with a 1 mm 
gap cuvette by 1.8 kV (BioRad) into the EP-competent cells, pre-incubated for 2 hours at 32˚C, 
and selected on an LB agar-plate containing 12.5 g/ml chloramphenicol and 12.5 g/ml 
Kanamycin/Ampicillin for ~40 hours at 32˚C. Starting with the culture of EL250 cells which 
harboured the BAC clone of interest, from 15 ml we obtained ~100 colonies from the heat-
shocked cell plate after the EP, with more than 90% of the colonies containing precisely the 
modified BAC clone. To excise the selection cassette from the modified BACs, arabinose was 
added to the log phase liquid culture of the selected clone, with the correct recombinant BACs 
at 0.1% v/v for 1 hour at 32˚C so as to sufficiently induce the Flpe gene in EL250 cells. The loss 
of the selection cassette was monitored on the L-plate containing the antibiotic for the selection 
cassette. Homologous recombination events were always verified by PCR and/or 
electrophoresis after purification of the BAC DNA from each colony, as mentioned below. 
2.2 BAC purification and evaluation 
In order to obtain sufficient BAC DNA for PCR based clone selections, pulse field gel 
electrophoresis (PFGE) mediated evaluations and/or direct sequencing, around 3~6 ml 
liquid culture was inoculated for each colony. Prior to the purification of the BAC DNA, 400 
l of the saturated culture was mixed with 80 l of 40% glycerol solution and stored at -80˚C. 
The general protocol to purify the plasmid DNA was modified for the BAC DNA as follows: 
a bacterial cell pellet from the saturated culture (up to 3 ml) was collected into a 1.5 ml tube 
by serial centrifugations, and was suspended into 100 l of solution I. The suspension was 
gently lysed by adding 200 l of freshly prepared solution II (slowly inverting the tube four 
times so as to make the suspension nearly transparent) and carefully neutralised by adding 
150 l of cold solution III (gently inverting the tube twice to mix the contents evenly). After 
centrifugation at 15,000 rpm for 10 min at 4˚C, the supernatant was overlaid on 500 l of 
phenol chloroform mixture, and the content was evenly blended by gently shaking the tube 
three times. After centrifugation at 15,000 rpm for 5 min at room temperature, the upper-
layer was transferred to a 1.5 ml tube filled with 350 l of isopropanol, mixed and reserved 
at -30˚C for at least 30 min. After centrifugation at 15,000 rpm for 10 min at 4˚C, the pellet 
including the BACs and RNA was washed with 75% ethanol and dissolved into 30 l of 
distilled water (DW) containing RNase at 60˚C for 10min. 7.5 l of the BAC solution can be 
used for visualising the DNA fragment on normal 0.6% agarose/TAE gel electrophoresis or 
1% agarose/TBE PFGE. For sequencing, polyethyleneglycol-based precipitation was carried 
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out overnight at 4˚C, and the pellet was dissolved into DW to measure the optical density at 
OD260 by NanoDrop (Thermo Fisher Scientific).  
To obtain good amounts of BAC DNA with high quality for trans-genesis, a CsCl density 
gradient ultracentrifugation-based purification method or a purification kit (NucleoBond 
BAC 100, Macherey-Nagel) were utilised. For CsCl purification, 1,500 ml LB was inoculated 
for each clone from the glycerol stock. For the kit, 250 ml of the culture was harvested and 
BAC DNA was purified as the manufacture’s protocols recommended. 
2.3 BAC trans-genesis 
All the animal experiments in this study conform to Japanese governmental guidelines and 
have been approved by the Animal Care and Use Committee of the National Institute of 
Neuroscience (Projects 2007022 and 2011007). For microinjection of BAC DNA into fertilised 
mouse eggs, an engineered BAC clone was linearised by PI-SceI, purified by ethanol 
precipitation and dialysed on a filter membrane (Millipore VMWP-pore size 0.05m) to the 
BAC injection buffer, containing 10 mM Tris-HCl pH 7.5, 0.1 mM EDTA, 100 mM NaCl, 30 
M spermine (tetrahydrochloride; Sigma S-1141) and 70 M spermidine (trihydrochloride; 
Sigma S-2501) for 2 hours. The quality of the DNA was evaluated by NanoDrop (Thermo 
Fisher Scientific) and the linearised BAC solution was diluted to ~2 ng/l by the BAC 
injection buffer and was microinjected into pronuclei of the mouse-fertilised eggs prepared 
from the superovulated B6C3F1 mouse strain (SLC, Japan or Charles River, Japan). 
Generally, ~10 transgenic founders were obtained from ~200 eggs injected. 
For the genotyping of the transgenic mouse founders or embryos, tails or yolk sacs were 
collected and treated with 100 g/ml Proteinase K (Wako, Japan) at 55˚C for several hours 
in a tail buffer containing 10 mM Tris pH7.5, 100 mM NaCl, 1 mM EDTA and 1% SDS. After 
heating at 95˚C for 5 min, these samples were extracted once with a phenol chloroform 
mixture and stored at -20˚C. To determine their genotypes, PCR was performed with the 
primer sets covering exogenous gene cassettes, such as LacZpA. The presence of RP23/24 
vector sequences immediately upstream or downstream of the PI-SceI site was further 
examined by PCR so as to minimise the possibility that fortuitous large deletions fell onto 
the BACs which had been integrated into the chromosome. 
2.4 The detection of beta-galactosidase activities or green fluorescent protein in brain 
slice preparations 
In order to make brain slices only for the mice harbouring BAC-beta-galactosidase 
transgenes, we devised the rapid genotyping method for BAC transgenic pups to be finished 
during the morning of the day for brain dissection and slicing, as transgenic mice were 
always kept with the transgene being hemizygous, and were inter-crossed with B6C3F1 wild 
type mice (anticipating the delivery of transgenic pups at a 50% probability). Briefly, the 
cranial part of a mouse pup was anesthetising on ice and was placed into a chamber of the 12-
well dish and filled with ice-cold Tyrode’s solution. The tail was cut at the same time, and put 
into 100 l of tail buffer containing 100 g/ml of Proteinase K (see above). After finishing the 
collecting of the cranial parts and tails from a litter, the tail samples were incubated at 55˚C 
for ~40 min with thorough voltexing in every 10 min. The tail samples were heated at 95˚C 
for 5 min and extracted once with a phenol chloroform mixture. A PCR for genotyping was 
then performed, as described earlier (Inoue et al., 2008). While the PCR was running, the 
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whole brain was dissected out from the cranial part and fixed in a phosphate-buffered saline 
(PBS pH7.4) containing 1% paraformaldehyde, 0.1% glutalaldehyde, 2 mM MgCl2, 5 mM 
EGTA and 0.02% Igepal CA-630 (NP-40; Sigma) for 90 min on ice. After a washing for the 
fixative by the washing buffer (WB: PBS containing 0.02% Igepal CA-630), these whole brain 
samples were kept in WB on ice. In the afternoon, we embedded only those brains confirmed 
to be positive for the transgene by PCR in 2% agarose/PBS, and made 550 m slices by using 
a microslicer (DTK-3000, D.S.K., Kyoto). The slices were then incubated in the staining 
solution, containing 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6 ·3H2O, 2 mM MgCl2, 0.01% sodium 
deoxycholate, 0.02% Igepal CA-630 and 0.1% X-gal (Wako, Japan) for several hours at 37˚C 
with gentle agitations. The colour-detection was stopped by several washings with WB, and 
samples were post-fixed overnight in a PBS containing 5 mM EDTA, 1% paraformaldehyde, 
0.1% glutalaldehyde and 0.02% Igepal CA-630 at 4˚C. After washings with WB, the samples 
were finally stored at 4˚C in a PBS containing 1 mM EDTA and 0.02% Igepal CA-630. For 
analysis, stained slice samples were put on 2% agarose/PBS plate filled with a PBS solution 
and flattened by a cover glass. Sample images were then captured under binocular 
microscope (MZ8, Leica) equipped with a CCD camera (DFC300FX, Leica) and printed out by 
using a video printer (SCT-CP7000, Mitsubishi, Japan). 
For preparing the brain slices for the mice that harbour BAC-GAP43-EGFP transgenes, the 
whole brain was dissected out and illuminated under a fluorescent binocular microscope 
(FLIII, Leica) so as to easily select the transgenic brain. Transgenic brains were fixed in 2% 
paraformaldehyde/PBS for 1 hour and embedded in 2% agarose/PBS. 550 m slices were 
then made by using the microslicer and photographs were taken under the microscope 
(FLIII, Leica) equipped with a CCD camera (DFC300FX, Leica). 
2.5 Retinoic acid administration to mouse embryos and pups 
To administer retinoic acid (RA; Sigma #2625 or ITSUU laboratory), the stock solution was 
prepared with a concentration of 30 mg/ml, and 1ml of the 1/1000 diluent (30 g) was 
intraperitoneally administrated to the mother or the pups, per 1g of body weight (Smith et 
al. 2001). 
2.6 Solutions used in the present study 
LB: One litre of LB solution contains 10 g of Tryptone (BD Biosciences), 5 g of Yeast Extract 
(BD Biosciences), 5 g of NaCl and 4 ml of 1N NaOH. The solution is stored at room 
temperature after autoclave. 
Solution I for BAC purification: This solution contains 50 mM glucose, 25 mM Tris-Cl (pH 8.0) 
and 10 mM EDTA (pH 8.0). The solution was stored at room temperature. 
Solution II for BAC purification: This solution contains 1% sodium dodecyl sulphate (SDS) and 
0.2N NaOH. To obtain a good amount and the purity of the BACs, the solution was freshly 
prepared from 10% SDS and 2N NaOH stock solutions stored at room temperature. 
Solution III for BAC purification: 3M potassium acetate was dissolved into distilled water and 
the pH is adjusted with formic acid to 4.8. We store the solution at -20˚C. 
Phenol Chloroform mixture: 10mM Tris-Cl saturated phenol solution was mixed with the 0.96 
volume of chloroform and 0.04 volume of isoamyl alcohol. The mixture was stored at 4˚C. 
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PBS: One litre of 10x PBS stock contains 80 g of NaCl, 2 g of KCl, 11.5 g of Na2HPO4 and 2 g of 
KH2PO4. We sterilised the stock solution by autoclaving and stored it at room temperature. 
TAE: One litre of 50x TAE solution contains 242 g of Tris-Cl, 57.1 ml of CH3COOH and 100 
ml of 0.5M EDTA (pH8.0). 
TBE: One litre of 10x TBE solution contains 108 g of Tris-Cl, 55 g of boric acid and 40 ml of 
0.5M EDTA (pH8.0). 
Tyrode’s solution: Five litres of Tyrode’s solution contains 40.0 g of NaCl, 1.0 g of KCl, 1.0 g of 
CaCl2, 1.05 g of MgCl2·6H2O, 0.285 g of NaH2PO4·2H2O, 5.0 g of NaHCO3 and 5.0 g of 
glucose. To avoid the possible precipitation of salts, we added these reagents in this order 
and sterilised by filtration and stored at 4˚C. 
3. Results and discussions 
3.1 Cdh6 gene expression along cortical layer IV neurons in the mouse primary 
somatosensory barrel field is regulated by an inter-genic region 
The cerebral cortex (also called the ‘neocortex’ or the ‘isocortex’) is a mammal-specific brain 
region with layered cellular organisation in its radial direction (Rakic, 1988). It can further be 
subdivided into functional areas in its tangential direction, with each area harbouring distinct 
layer components, constituting fundamental units for higher brain functions that are unique to 
mammals (O’Leary et al., 2007). How this characteristic brain region can emerge during 
development as well as through evolution has been one of the important research subjects in 
the field of neuroscience; however, little is known about the genetic cascade required to 
elaborate the intricate cytoarchitecture in the cerebral cortex. In this context, classic cadherins 
have very unique features in their expression patterns: each cadherin subclass shows a distinct 
cortical layer and/or area specificity at the perinatal stages in mouse and other mammalian 
species, such as ferrets and humans (Krishna-K et al., 2009; Suzuki et al., 1997; Wang et al., 
2009). Classic cadherins might, therefore, provide ideal genetic clues in systematically 
understanding the molecular mechanism of cortical development. 
In the previous studies, we have focused on mouse cadherin-6 (Cdh6), one of classic 
cadherin subclasses whose expression demarcates subsets of cortical layers and/or areas 
(Suzuki et al., 1997; Inoue et al., 1998), and we found out that a 58 kbp long 3 prime territory 
to mouse Cdh6 gene (Segment X in Inoue et al., 2008a) is required for its mRNA expression 
along the cortical layer IV-barrel neurons in the primary somatosensory area (S1) at 
postnatal day 7 (P7; Inoue et al., 2008b; our unpublished data). In the present study, we 
sought to further narrow down the responsible territory for the expression by systematically 
deleting genomic regions from the reporter modified BAC clone that can recapitulate Cdh6 
expression in S1-barrel layer IV neurons at P7. To this end, we first referred to the 
evolutionary conserved region (ECR) browser in which conserved genomic regions among 
various species are aligned and annotated (http://ecrbrowser.dcode.org). Compared with 
human and dog genome sequences, as many as 60 ECRs – with more than 70% similarities 
in a window larger than 100 bp – were found in Segment X (data not shown), and we 
roughly divided Segment X into three regions (regions a~c in Figure 1) by means of ECR 
locations. We then sought to differentially delete two of the regions in Segment X from the 
reporter modified BAC clone RP23-78N21 so as to effectively narrow down the responsible 
territory (Asami et al., 2011; Constructs #1 and #2 in Fig. 1). We subsequently obtained three  
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Fig. 1. An intergenic segment of mouse Cdh6 is found to be necessary for the postnatal barrel 
area specific expression in the cerebral cortex.  
The uppermost part of the figure indicates the genomic structure of mouse Cdh6, with its 
exons being designated by short vertical lines. ATG, translation start site; TSS, transcription 
start site. A BAC clone RP23-78N21 is initially modified to harbour a beta-galactosidase gene 
cassette and a SV40 polyadenylation signal (LacZpA) in a frame to the Cdh6 gene via 
homologous recombination (Rec) in a recombinogenic bacterial strain. This original BAC is 
further engineered by homologous recombination so as to generate deletion constructs 
#1~#3. Note that transgenic (Tg) mice with original BACs and construct #2 strongly 
recapitulate the somatosensory barrel-specific expressions (black arrow heads), while those 
with constructs #1 and #3 do not yield the expression at the postnatal day 7 (P7; white 
arrow heads). From these results, a 5840-bp territory (orange box) is determined to be a 
critical regulatory region for the barrel-specific expression of Cdh6 at P7. At the upper left 
corner of each panel, the ratio of brain samples exhibiting reproducible reporter expression 
over the total number of independent transgenic mouse lines generated is noted. 
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stable, independent BAC transgenic (Tg) mouse founders from Construct #1 and five from 
Construct #2. In the former founders, none of them recapitulated the reporter expression in 
S1-barrel layer IV neurons (Fig. 1, white arrow heads), which are strongly marked by the 
original BAC trans-genesis (Fig. 1, black arrow heads). In contrast, four out of five founders 
reproduced the intense expression profile of S1-barrel layer IV neurons, while one of them 
showed no reporter expression in the brain (probably due to the positional effect of the 
BACs’ integration site). From these results, it is strongly suggested that the most 5 prime 
third of Segment X (region a in Fig. 1) is responsible for Cdh6 expression in the S1-barrel 
layer IV neurons at P7. 
In order to further to narrow down the responsible territory, we designed the Construct #3 
in which a fragment containing the most 3 prime third of region a is excluded from the 
original BACs. Among seven Tg founders generated from Construct #3, we could not 
observe the intense reporter expression of S1-barrel layer IV neurons at all (white arrow 
heads in Fig. 1), while we found that neurons in the other cortical layers (i.e. layers II/III) 
and/or areas at P7 maintained their conspicuous expression compared to the original Cdh6-
BAC-Tg lines (Fig. 1). Taken together, we concluded that a 5,884 bp territory containing 11 
ECRs is required for Cdh6 expression in S1-barrel layer IV neurons at P7. 
To our knowledge, this is the first time that a distinct gene regulatory fragment for a 
defined layer and/or area has been observed, suggesting that separable genetic programs 
may serve the pattering of each cortical layer and/or area during development. The 
further characterisation of the gene regulatory elements that directly interact with the 
5,884 bp territory would be an important next step in understanding how the cortical 
layer and/or area identity is strictly determined during development. In this connection, 
it is noticeable that the 5,884 bp territory contains many of the transcription factor binding 
motifs, such as RORbeta, whose expression is already known to be restricted to defined 
sets of cortical layers and/or areas (Dye et al., 2011; Hirokawa et al., 2008; Nakagawa & 
O’leary, 2003). Since recent reports suggest that RORbeta harbours an instructive role in 
elaborating barrel cytoarchitecture and/or circuitries (Jabaudon et al., 2011), it would be 
of great interest to rigorously evaluate how these transcription factors are involved in 
establishing Cdh6 expression along S1-barrel layer IV neurons at P7 which might have 
functional significance in driving cell segregations to form and/or maintain the barrel 
cytoarchitecture. 
3.2 Retinoic acid (RA) related cell signalling machineries might be involved in the 
cortical barrel patterning 
RA signalling regulates many of the morphogenetic events at the early embryonic stage, 
such as A-P axis formation, the establishment of L-R asymmetry and so on (Kiecker & 
Lumsden, 2005; Niederreither & Dolle, 2008). It has recently been suggested that RA 
might also have physiological roles in cortical development at the later embryonic stages 
(Siegenthaler et al., 2006; Smith et al., 2001). We thus next tried to examine the possible 
roles of RA related cell signalling machinery in the cortical area pattering during 
development. By using the same BAC clone RP23-78N21, we replaced the Cdh6-ATG exon 
to an expression cassette for the membrane-bound form of enhanced green fluorescent 
protein (GAP43-EGFP) by means of homologous recombination and generated transgenic  
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Fig. 2. Possible involvement of retinoic acid (RA) related cell signalling machineries in the 
cortical barrel patterning.  
A BAC clone RP23-78N21 is modified to harbour a membrane-bound form of EGFP cassette 
and SV40 polyadenylation signal (GAP43-EGFP-pA) in frame to the Cdh6 gene via 
homologous recombination (Rec) in a recombinogenic bacterial strain (upper most part of 
the figure). (A-D) A Tg mouse with EGFP modified BACs recapitulated Cdh6 expression at 
P7. OB, olfactory bulb; S1 primary somatosensory area. The boxed area d in panel C is 
magnified in panel D. Note that Layer IV barrels in S1 are illuminated in this Tg mouse line. 
(E-H) Effects of RA on barrel development. RA is intraperitoneally injected into the mother 
(E, F) or the pups (G, H) and the EGFP expression profile is evaluated at P7. Note that this is 
only the case with E14.5 injections, which affect the formation of barrel cytoarchitecture, 
highlighting the role of RA in early neocortical development.  
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mouse founders (Inoue et al., 2009). In the Tg cerebral cortex, we found that GFP expression 
shows exactly the same patterns as with the original LacZ-Tg mice (Fig 1 and 2). In 
particular, this GFP-BAC-Tg mouse line illuminated the S1 barrel structure of the whole 
mount brain preparations, allowing us to easily image the S1-barrel territory whose 
identification generally requires specific histological staining processes, such as the CO 
staining method.  
We then administrated RA to the mothers or pups for GFP-BAC-Tg, with the 
concentration reported to induce abnormality in the cortex (Smith et al., 2001) and 
evaluated how RA affects the GFP expression patterns at P7. As a result of this, no drastic 
change was observed for the cortical barrel patterning when RA was administrated later 
than embryonic day 17.5 (E17.5). However, RA administration at E14.5 resulted in 
massive perturbation of S1 barrel patterning, with ambiguous area boundaries 
illuminated by GFP expression. Noticeably, the intensity of the GFP expression appeared 
to be decreased due to the qualitative and quantitative differences among Cdh6::GFP 
positive cortical cells and/or thalamocortical axon terminals. These results imply that the 
role of RA in regulating Cdh6 expression and/or cortical area pattering is just limited to 
those embryonic stages earlier than E14.5. 
It is now widely accepted that cortical area patterning begins as early as mouse E12.5 when 
the counter-gradient of the transcription factors Pax6 and Emx2 is established in the cortical 
ventricular zones (Bishop et al., 2000; Hamasaki et al., 2004). This gradation pattern, as 
generated by such secreted molecules as Fgf8, is shown to be the basis of cortical arealisation 
yet other transcriptional factors, such as Coup-TFI, could regulate the area-specific 
differentiation of distinct subtypes of cortical neurons independently of Fgf8-Pax6/Emx2 
gene functions (Armentano et al., 2007; Fukuchi-Shimogori & Grove, 2001, 2003). Our 
results, together with a previous series of studies, thus suggest that RA accumulated earlier 
than E14.5 might play a role in cortical arealisation by affecting the production, migration, 
positioning and/or circuit formation of the cortical S1 barrel layer IV neurons that 
eventually express Cdh6. The next critical step would be to examine whether RA-related 
signalling could be interactive with the 5,884 bp territory identified in this study that 
contains RORbeta related transcription factor binding motifs. 
3.3 BACs in the field of neuroscience research 
In the present study, BAC-based methodology enabled us to systematically evaluate 
intricate genetic machineries in the mouse brain, highlighting the value of BAC usage in the 
field of neuroscience research. Recently, others have also developed many useful BAC-
based strategies, and here we discuss the advantages and/or future potential of some of 
these strategies in the field of neuroscience research.  
First, we have realised that BACs must provide a useful and ideal basis in approaching the 
complex gene regulatory machinery that elaborates the nervous system. For instance, a 
difficulty involved in studying the vertebrate nervous system has lain in its complexity and, 
when we try to rigorously dissect its specialised structure and function, it should be an 
essential step in discriminating a defined group of cells among numerous neurons and glial 
cells. As has been demonstrated by the present study, homologous recombination-based 
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systematic deletions from BAC clones combined with efficient mouse trans-genesis now 
allows for the quick identification of cis-regulatory elements from the huge Cdh6 gene locus, 
which contrasts with the conventional methodology where hundreds of conserved genomic 
regions must be evaluated one-by-one by means of plasmid-based methods (See discussions 
in Asami et al., 2011). A problem with this recombination-based method might lie in its limit 
for BAC clone usage, since the BAC clone for recombination must always include an ATG 
translation initiation codon for the gene of interest to achieve in-frame integration of the 
reporter cassette. This being the case, cis-regulatory elements located far outside of the ATG-
containing BAC clone cannot also be treated by this method. However, if combined with the 
transposon-based BAC modification method, one can reliably monitor the gene 
transcriptional activity of any BAC clones, regardless of their gene/ATG-exon coverage 
(Asami et al., 2011). Hence, a BAC-based strategy would greatly help the understanding of 
the upstream/downstream relationships among thousands of genes that are preferentially 
expressed in the nervous system, revealing the entire genetic programmes for building up 
the nervous system. Noticeably, many human single nucleotide polymorphisms (SNPs) that 
are tightly linked to genetic disorders have been identified in the intergenic regions (Wang 
et al., 2009). These SNPs are thought to play roles in regulating gene expression and/or 
chromosomal structures, yet the methodologies that can reliably detect their functional 
significance are limited in number at the present time. In this context, our BAC-based 
methodology could immediately serve as a steadfast platform in approaching such critical 
research subjects (Asami et al., 2011).  
Secondly, we have demonstrated that BAC-based methodology is very useful for the stable 
and efficient labelling of distinct cells-types during neural development. Since fluorescent 
proteins – such as GFP – can easily visualise cell morphology, they have been broadly used, 
from basic molecular-cell biology to biomedical studies. In the field of neuroscience 
research, it remains a fundamental issue to thoroughly identify the original location of 
neurons and their partners among the billions of neurons, since they often make contact 
with other neurons located far away from the soma. For this purpose, the use of a 
membrane localisation signal, such as GAP43 tagged GFP, would clearly visualise axons, 
while nuclear localisation signal-based reporter introduction would precisely identify the 
soma location. Recently, a rabies virus mediated single synaptic transfer event was applied 
so as to enable systematic labelling of both the starter neurons and their primary partners in 
connections (Miyamichi et al., 2011). However, in order to restrict the number of neurons 
labelled by this method in the nervous system, it is most critical to identify 
enhancers/promoters that confine gene expression in the limited population of cells 
amongst the tens of thousands of neurons. In this context, BACs do provide an ideal 
resource for such an analysis because we can now easily engineer a given BAC clone to 
include sets of enhancers/promoters for obtaining restricted gene expression profiles, and 
the GENSAT project indeed generated hundreds of BAC transgenic mouse lines that 
differentially illuminate specific sets of cells in the nervous system (Gong et al., 2003; Gong 
et al., 2010). If a GFP tagged L10a ribosomal protein is expressed by BAC trans-genesis, the 
mRNA expressed in the specific set of cells should be illuminated and can further be 
isolated by the fluorescent activated cell-sorting system so as to profile their molecular 
characteristics (Heiman et al., 2008). 
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Thirdly, a BAC-based methodology is highly expected to open a new window into the study 
of unknown processes for brain development and/or the functional dynamics of neural 
circuitries. For instance, in multicellular model organisms, such as the mouse, the fly and the 
nematode, loss of function studies are currently the gold standard for revealing given gene 
functions, contributing to the revelation of genetic programmes at the early developmental 
stages. There had been, however, a problem in that a simple loss of function analysis 
sometimes results in early embryonic lethality, preventing researchers from evaluating the 
gene functions in mature organs, such as brains. To circumvent this situation, a conditional 
gene knock-out strategy was established so that a given gene function is abolished at a 
defined time and place by genetically introducing the enhancer-driven site-specific 
recombinase Cre and its recognition sites LoxP sequences into the gene locus of interest. 
Considering their extensive coverage of various enhancers/promoters in the genome of 
multicellular model organisms, BAC clones should serve as the perfect starting points in the 
establishment of useful driver transgenic animals for conditional knock-out studies. 
Additionally, if the expression cassette for Cre and the estrogen receptor T2 variant fusion 
protein (CreERT2; Feil et al., 1997) is integrated into a proper BAC clone to generate Tg 
animals in which CreERT2 proteins are expressed among a limited group of cells, one can 
precisely control the timing to generate gene mutant cells by merely administrating 
tamoxifen, which allows selective CreERT2 localisation into the cell nuclei so as to excise the 
gene of interest by recombination. CreERT2-Tg animals might further be suitable for genetic 
cell-lineage tracing. In the mouse system, this can generally be achieved by using the 
reporter mouse lines, such as Rosa26R, in which LacZ reporter expression is suppressed by 
the intercalation of a stopper put in between the LoxP sequences. When this reporter line is 
mated with the CreERT2-Tg mouse line, the stopper is excised only with the administration 
of tamoxifen and, thereafter, a limited population of cells will be genetically and 
permanently marked by the reporter expression. Indeed, we have generated the 
Cdh6::CreERT2-BAC-Tg mouse to clarify the relationship between the Cdh6 gene expression 
boundary at the early cortical plate and the mature areal boundary, and have found a rigid 
correlation (Terakawa et al., manuscript submitted). Useful CreERT2-Tg mouse lines could 
be further be mated with the recently created Brainbow mouse Tg line, logically allowing 
the genetic labelling of individual cells in the nervous system by different fluorescent colour 
combinations (Livet et al., 2007). Such spatio-temporally regulated labelling of cells must aid 
in unveiling the functional dynamics of the nervous system in higher vertebrates with 
complex cellular organisation. 
To finally address the fundamental question as to how the elaborated neural circuitries 
work in the in vivo context, the BAC-based introduction of optogenetic probes, such as 
channel rhodopsin and halorhodopsin, into specific sets of neurons might make it possible 
to selectively switch on and off neuronal activities within the regions that receive the 
relevant light stimuli (O’Connor et al., 2009; Zhang et al., 2007). Since the individual 
optogenetic probe harbours different wavelengths’ selectivity, defined sets of neuronal 
and/or muscle activities can be manipulated by simply applying combinatorial light stimuli 
to the Tg animals. This technology therefore speeds the detailing of which circuitries are 
actually responsible for a given behaviour and/or the process for learning and memory, 
exemplifying how BAC-related experimental methods can be applicable to wide range of 
research in the field of neuroscience. 
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Taking advantage of systematic BAC modification methodologies via homologous 
recombination and/or transposon tagging in bacterial cells, as well as efficient BAC 
transgenic strategies in various multicellular organisms, such as mice, it is now possible to 
mark and manipulate a given gene function amongst restricted cell groups in the nervous 
system at will. Given that BACs constitute the minimal components of various whole 
genome-sequencing projects, BAC-based technology would significantly facilitate the detail 
of entire genetic programmes that elaborate the complex structure and function of the 
nervous system, including our own. Such detailed information would greatly help the 
appreciation of the intricate principles of neural evolution and development, encoding, 
processing and/or pathogenesis. 
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